Skip to Content
Merck

SML1349

SB-207266

≥98% (HPLC)

Synonym(s):

1′-Butyl-4′-piperidinylmethyl ester, 8-Amino-7-chloro-2,3-dihydro-1,4-benzodioxan-5-carboxylic acid, N-1-Butyl-4-piperinylmethyl)-3,4-dihydro-2H-[1,3] oxazino[3,2-a]indole-10-carboxamide, Piboserod

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C22H31N3O2
CAS Number:
152811-62-6
Molecular Weight:
369.50
NACRES:
NA.77
PubChem Substance ID:
329825805
UNSPSC Code:
12352200
MDL number:
MFCD00923681
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
100

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

KVCSJPATKXABRQ-UHFFFAOYSA-N

SMILES string

O=C(NCC1CCN(CCCC)CC1)C2=C3N(CCCO3)C4=C2C=CC=C4

InChI

1S/C22H31N3O2/c1-2-3-11-24-13-9-17(10-14-24)16-23-21(26)20-18-7-4-5-8-19(18)25-12-6-15-27-22(20)25/h4-5,7-8,17H,2-3,6,9-16H2,1H3,(H,23,26)

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 5 mg/mL, clear (warmed)

storage temp.

2-8°C

Quality Level

100

Biochem/physiol Actions

SB-207266 is a Serotonin 5-HT4 receptor antagonist in vivo.
SB-207266 is a potent, selective, orally active and long-acting 5-HT4 antagonist in vivo.

pictograms

Skull and crossbones
GHS06

signalword

Danger

hcodes

H301

Hazard Classifications

Acute Tox. 3 Oral

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
095M4728V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Barbora Waclawiková et al.
PLoS biology, 19(1), e3001070-e3001070 (2021-01-23)
Microbial conversion of dietary or drug substrates into small bioactive molecules represents a regulatory mechanism by which the gut microbiota alters intestinal physiology. Here, we show that a wide variety of gut bacteria can metabolize the dietary supplement and antidepressant

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service